Ctcae version
Found 5 free book(s)
Common Terminology Criteria for Adverse Events (CTCAE)
www.jcog.jpCommon Terminology Criteria for Adverse Events (CTCAE) Version 4.0 Published: May 28, 2009 (v4.03: Jun. 14, 2010) 有害事象共通用語規準 v4.0日本語訳JCOG 版（略称：CTCAE v4.0 - JCOG） [CTCAE v4.03/MedDRA v12.0（日本語表記：MedDRA/J v13.1）対応 - 2010年9 月11 日]
CRITERES DE TOXICITE NCI-CTC Version 4 - cepd.fr
www.cepd.frNCI-CTC Version 4.0 3 COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS V4.0 (CTCAE) Date de publication : 28 mai 2009 La terminologie NCI CTCAE est une terminologie descriptive pouvant être utilisée pour la déclaration des
Common Terminology Criteria for Adverse Events (CTCAE)
www.jcog.jpCTCAE はv4.0への改訂に伴い、Medical Dictionary for Regulatory Activities （MedDRA）へ完全準拠 した。オリジナルCTCAE v4.0の初版はMedDRA v12.0に対応し、その日本語訳の初版は日本語版MedDRA
Breast Pathway Group Paclitaxel weekly in Advanced Breast ...
www.londoncanceralliance.nhs.ukBreast Pathway Group – Paclitaxel weekly in Advanced Breast Cancer Version: 1.0 Supersedes: all other versions Approved by LCA Breast Pathway Chemotherapy Lead: Mark Harries November 2014
NEW ZEALAND DATA SHEET VOTRIENT 200 mg and 400 mg …
www.medsafe.govt.nzNEW ZEALAND DATA SHEET VOTRIENT® Film coated tablet Page 4 of 27 VOTRIENT is contraindicated in patients with hypersensitivity to the active substance pazopanib hydrochloride or to any of the excipients listed in section 6.1.